drugset / Trial / NCT03022877

Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions

NCT03022877

RandomizedParallel-groupSingle-blindTreatment

Summary

In the proposed project the investigators want to assess whether the approach of the post-conditioning by Levosimendan in patients with acute STEMI is safe and reproducible, can be used with a positive influence on the outcomes with respect to myocardial damage, cardiac left ventricular remodeling, myocardial function, the occurrence of cardiac events and quality of life.

Timeline

Start
2017-06
Primary completion
2018-12
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levosimendan Other / unclassified 0.1 ug/kg Intravenous
Comparator Levosimendan Other / unclassified 0.2 ug/kg Intravenous
Comparator Levosimendan Other / unclassified 12 ug/kg Intravenous

Indications